Sympathetic ophthalmia in VATER association combined with persisting hyperplastic primary vitreous after cyclodestructive procedure

European Journal of Ophthalmology

Volumn 16, Issue 1, 2006, Pages 171-172

  Jonas, J B ^a,b   Back, W ^a   Sauder, G ^a   Junemann U ^a   Harder, B ^a   Spandau, U H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cyclocryocoagulation; Cyclophotocoagulation; Iritis; Persisting hyperplastic primary vitreous; Sympathetic ophthalmia; Uveitis

Indexed keywords

CYCLOSPORIN; METHOTREXATE; PREDNISOLONE;

ADOLESCENT; ARTICLE; CASE REPORT; CLOSED ANGLE GLAUCOMA; CRYOCOAGULATION; CYCLOCRYOCOAGULATION; CYCLOPHOTOCOAGULATION; DISEASE ASSOCIATION; ENUCLEATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IRIS NEOVASCULARIZATION; IRITIS; LASER COAGULATION; MALE; MICROPHTHALMIA; NEOVASCULARIZATION (PATHOLOGY); PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SYMPATHETIC OPHTHALMIA; SYNDROME VATER;

EID: 33645540300     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600129     Document Type: Article

References (5)

1. Quan L, Smith DW. The VATER association. Vertebral defects, anal atresia, T-E fistula with esophageal atresia, radial and renal dysplasia: a spectrum of associated defects. J Pediatr 1973; 82: 104-7.
2. Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997; 124: 587-626.
3. Lam S, Tessler HH, Lam BL, Witensky JT. High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy. Ophthalmology 1992; 99: 1818-22.
4. Brown SV, Higginbotham E, Tessler H. Sympathetic ophthalmia following Nd:YAG cyclotherapy. Ophthalmic Surg 1990; 21: 736-7.
5. Bechrakis NE, Muller-Stolzenburg NW, Helbig H, Foerster MH. Sympathetic ophthalmia following laser cyclocoagulation. Arch Ophthalmol 1994; 112: 80-4.